Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous stock reports and market updates.
Haemonetics Corporation (NYSE: HAE) shares increased 2.38 percent to close at $37.00 a share Friday. The stock traded between $36.23 and $37.03 on volume of 1.10 million shares traded. Analysts at Sidoti have recently upgraded the company’s rating to “buy” from “neutral”. Shares of Haemonetics have fallen approximately 12.0 percent year-to-date.
Find out more about Haemonetics including full access to the free equity report at:
www.RDInvesting.com/HAE
NutriSystem Inc. (NASDAQ: NTRI) shares increased 4.19 percent to close at $14.66 a share Friday. The stock traded between $13.97 and $14.80 on volume of 1.25 million shares traded. Analysts at Sidoti have recently upgraded the company’s rating to “buy” from “neutral”. Shares of NutriSystem have fallen approximately 10.0 percent year-to-date.
Find out more about NutriSystem including full access to the free equity report at:
www.RDInvesting.com/NTRI
Omnicare, Inc. (NYSE: OCR) shares increased 3.38 percent to close at $59.68 a share Friday. The stock traded between $59.57 and $60.62 on volume of 1.82 million shares traded. Analysts at UBS have recently upgraded the company’s rating to “buy” from “neutral”. Shares of Omnicare have fallen approximately 1.0 percent year-to-date.
Find out more about Omnicare including full access to the free equity report at:
www.RDInvesting.com/OCR
Quality Systems, Inc. (NASDAQ: QSII) shares gained 2.68 percent to close at $17.62 a share Friday. The stock traded between $17.50 and $17.79 on volume of 553,765 shares traded. Analysts at FBR Capital have recently upgraded the company’s rating to “market perform” from “underperform”. Shares of Quality Systems have fallen approximately 16.0 percent year-to-date.
Find out more about Quality Systems including full access to the free equity report at:
www.RDInvesting.com/QSII
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.
Contact:
Research Driven Investing
[email protected]